Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Argent Biopharma ( (AU:RGT) ) has issued an announcement.
Argent Biopharma Limited announced the cessation of 50,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of June 30, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange under the code RGT.
Average Trading Volume: 49,032
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.07M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.